What LifeMD does

LifeMD, Inc. (NASDAQ: LFMD) is a publicly traded direct-to-consumer telehealth platform founded in 2013 and headquartered in New York City, operating a 50-state virtual care network organized around five vertical programs: weight management (with branded GLP-1 medications Wegovy, Zepbound, Ozempic, and Eli Lilly's oral Foundayo), women's health (hormone replacement therapy, menopause care, bone density), mental health, cardiovascular care, and 24/7 urgent/primary care under the LifeMD+ subscription. The platform is delivered through a proprietary technology stack combining video and message-based consultations, an affiliated medical group licensed across all 50 states, electronic health records, AI-assisted clinical documentation, and a vertically integrated in-house pharmacy operating under FDA 503A designation with up to 5,000 prescriptions per day capacity. Sub-brands include RexMD (men's health), ShapiroMD (dermatology/hair loss), Cleared (allergy/asthma), and NAVA MD.

The business model is predominantly subscription and transaction-based, with monthly memberships starting at $149 (first month $39 introductory) plus per-prescription medication fees that range from $149/month for oral GLP-1s to $499/month for Ozempic. LifeMD accepts major PPO insurance and Medicare for qualifying services and also sells through FSA Store and HSA Store partnerships. Go-to-market relies primarily on digital advertising and social media (Instagram, TikTok, LinkedIn, X) for top-of-funnel acquisition, with growing investor-conference-led B2B outreach toward employers and health plans. Strategic supply partnerships with Novo Nordisk (Wegovy subscription, NovoCare integration) and Eli Lilly (Foundayo) provide preferential access to in-demand GLP-1 therapies, while a $20M strategic investment from Medifast (December 2023) integrated OPTAVIA coaching into the weight management offering.

Following the November 2025 divestiture of its WorkSimpli software segment, LifeMD operates as a pure-play virtual care and pharmacy platform. Reported FY2025 revenue was approximately $194 million (up ~25% YoY), with the company swinging from a $21.4 million net loss in 2024 to $14.4 million of net income in 2025; FY2026 revenue is guided at $220-230 million. Active subscribers exceeded 322,000 across GLP-1 and women's health programs as of March 2026, and lifetime patient registrations reached over 745,000. The company has raised a $50 million revolving credit facility (January 2026) to support further corporate development.

Name

LifeMD

Legal name

LifeMD, Inc.

Website

https://lifemd.com

Company type

Public

Founded year

2013

Operating status

Operating

Headcount range

251–500 employees

Short description

LifeMD is a publicly traded, direct-to-consumer telehealth platform operating across all 50 U.S. states, offering subscription-based virtual care in weight management (GLP-1 medications), women's health, mental health, cardiovascular care, and 24/7 urgent/primary care, supported by an in-house 503A pharmacy.

Ownership category

akta.pro rank

Product category

Telehealth & Virtual Primary Care Services

NAICS

Offices of Physicians (6211), Offices of Physicians, Mental Health Specialists (621112)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Primary Care & General Medicine Virtual Care (HLALAAAA)

akta.pro secondary industries

Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN) (HLALADAD), Behavioral Health-Integrated Chronic Care (SUD comorbidity, collaborative care) (HLALAFAK)

Keywords

• Telehealth services
• Virtual primary care
• Weight management medications
• Hormone replacement therapy
• Online psychiatry services

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Marketing or Sales, Personnel, Technology or R&D, Supply Chain, Operations, Infrastructure

Revenue model

1. Telehealth Membership/Subscription: Monthly membership fees starting at $149 per month (first month discounted to $39) for access to provider consultations, care coordination, and ongoing clinical support across specialty programs.
2. Prescription Medication Sales: Revenue from dispensing GLP-1 medications (Wegovy, Zepbound, Ozempic, Foundayo), hormone replacement therapies, and other prescriptions. Pricing varies from $149/month for oral GLP-1s to $499/month for Ozempic, with insurance and cash-pay options.
3. Clinical Consultations: Fees for video visits, message-based consultations, and same-day prescription refills. Urgent and primary care services available 24/7 with varying consultation fees.
4. Laboratory Services: Revenue from diagnostic lab testing including hormone panels, cholesterol panels, thyroid function, diabetes tests, and inflammation markers. Labs ordered through Quest or Labcorp with affordable pricing.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

LifeMD operates a direct-to-consumer telehealth platform delivering virtual primary care, urgent care, and specialty programs across all 50 U.S. states. Core programs include GLP-1-based weight management (Wegovy, Zepbound, Ozempic, Foundayo), women's hormone health, mental health psychiatry, cardiovascular care, and 24/7 urgent care — supported by a vertically integrated mail-order pharmacy and AI-assisted clinical workflows.

Product overview

LifeMD is a direct-to-patient telehealth platform operating as a portfolio of brands offering virtual primary care, diagnostics, and specialized treatment across multiple verticals. The core platform provides 50-state telehealth services through a proprietary technology stack and affiliated medical groups (LifeMD Southern Patient Medical Care, P.C., LifeMD Atlantic Patient Medical Care, P.C., and others). Key products include LifeMD+ (membership-based urgent and primary care), the Weight Management Program (GLP-1 treatments including Wegovy, Zepbound, Foundayo), Women's Health Program (HRT and menopause care), Mental Health Program (psychiatric care), and Cardiovascular Health. The company also operates sub-brands including RexMD (men's health), ShapiroMD (hair loss/dermatology), Cleared (allergy/asthma), and NAVA MD. A vertically integrated pharmacy network with compounding capabilities supports medication fulfillment. The company divested its WorkSimpli software segment in late 2025 to focus purely on virtual care and pharmacy operations.

Differentiator

Problem solved

Functional benefit

Brands

• RexMD: Men's health telehealth brand offering treatments for conditions including erectile dysfunction, hair loss, and other men's health issues.
• ShapiroMD
• Cleared
• NAVA MD

Products and services

• LifeMD+ Urgent & Primary Care Subscription-based membership plan providing 24/7 access to urgent and primary care via video and message-based consultations, same-day prescriptions, and routine lab testing. No insurance is required; HSA/FSA eligible. Designed for individual consumers seeking convenient access to licensed healthcare providers for common concerns like colds, flu, rashes, and prescription refills.
• Weight Management Program Clinician-guided GLP-1 weight loss program offering access to branded GLP-1 medications (Wegovy injectable and pill, Zepbound, Ozempic, Mounjaro, Foundayo/orforglipron), with ongoing expert clinical guidance and insurance navigation support. Pricing starts at $149/month for cash-pay options and $0–$25 copays for commercially insured patients. Includes a Wegovy subscription program offering up to $1,200 in annual savings.
• Women's Health Program Personalized care program for women offering hormone replacement therapy (estradiol patches, topical gels, vaginal inserts, micronized progesterone) and lifestyle support to ease menopause symptoms, restore balance, and address bone density, metabolism, and wellness. Led by Clinical Chair Dr. Tara Scott and Clinical Lead Dr. Doug Lucas. Medicare accepted for qualifying virtual primary care services.
• Mental Health Program Affordable and accessible psychiatric care offering personalized treatment plans by licensed providers for conditions including anxiety, depression, performance/social anxiety, and related mental health concerns. Supports prescription medications such as Wellbutrin SR, Lexapro, Prozac, Buspar, Celexa, Cymbalta, Effexor, Zoloft, Paxil, and Inderal. Generic medications available.
• Cardiovascular Health Program Virtual cardiology program connecting patients with board-certified cardiologists to manage blood pressure, cholesterol, and long-term cardiovascular risk from home, with ongoing monitoring and consultation support.
• Insomnia Treatment Personalized care program for diagnosis and treatment of insomnia with ongoing provider support and prescription management where appropriate. Also offered through FSA Store and HSA Store partnerships for pre-tax benefit-eligible purchases.
• Lab Testing Services Affordable lab testing and analysis available through Quest Diagnostics and Labcorp partner networks, including diabetes, heart health, cholesterol, thyroid function, female and male hormone panels, and inflammation testing. Offered as a pay-as-you-go add-on to LifeMD programs.
• RexMD Men's virtual pharmacy and telehealth sub-brand offering discreet access to treatments for men's health conditions including erectile dysfunction and hair loss.
• ShapiroMD Telehealth sub-brand focused on hair loss and dermatological treatments.
• Cleared Allergy and asthma telehealth platform providing allergy and asthma care services, acquired by LifeMD in January 2022.
• NAVA MD Health and wellness brand operating under the LifeMD portfolio.
• LifeMD Affiliated Pharmacy (Mail-Order) In-house mail-order pharmacy network with capacity for up to 5,000 prescriptions per day, operating under FDA 503A non-sterile compounding designation, licensed in 13 states with planned expansion to all 50 states within 12 months. Supports dispensing of branded GLP-1 medications, hormone therapies, mental health prescriptions, and custom-compounded medications directly to LifeMD patients.
• Non-Sterile Compounding Pharmacy Services Advanced non-sterile compounding capabilities for oral and topical medications, enabling customized medications including allergen-free and combination products not commercially available, dispensed through the LifeMD affiliated pharmacy network.

Quantifiable outcome

• Average weight loss of ~33 lbs in 64-week medical study with Wegovy
• +4 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability3 records

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Eli Lilly and CompanycoreStrategic or Co-development Partner · 10 April 2026Partnership to offer Eli Lilly's FDA-approved weight loss drug Foundayo (orforglipron) through LifeMD's platform. Following FDA approval on April 1, 2026, Foundayo became available to eligible patients in the United States through LifeMD's weight management program, expanding access to oral GLP-1 therapies.
• Dr. Tara ScottminorOthers · 22 October 2025Dr. Tara Scott appointed as Ambassador and Clinical Advisor for LifeMD's Women's Health Program, focusing on menopause, hormonal balance, and long-term wellness. Role guides company outreach, education, and program development for underserved women's health needs.
• Health-E CommerceminorChannel Partner/ Reseller/ Distributor · 9 June 2025Collaboration to offer sleep treatments via FSA Store and HSA Store, expanding access to LifeMD services through employer-sponsored pre-tax healthcare benefit platforms. Partnership also includes weight management medications.
• Novo NordiskcoreStrategic or Co-development Partner · 22 May 2025Collaboration to launch $299 introductory bundle for self-pay patients prescribed Wegovy. Partnership expanded to include Wegovy subscription program offering up to $1,200 in annual savings, NovoCare Pharmacy integration for medication fulfillment, and availability of Wegovy pill. Deep collaboration covering both injectable and oral GLP-1 medications across all 50 states.
• Optimal Human Health MDcoreStrategic or Co-development Partner · 29 April 2025Acquisition of assets from Optimal Human Health MD to expand into the women's health market. Deal brought on board a team of nurse practitioners, registered dietitians, patient care staff, and founder Dr. Doug Lucas (specialist in osteoporosis reversal and hormone optimization), establishing clinical foundation for virtual women's health program.
• MedifastcoreStrategic or Co-development Partner · 13 December 2023Strategic collaboration involving $20 million investment from Medifast ($10 million support payment and $10 million stock purchase) to integrate Medifast's OPTAVIA coach-guided health program with LifeMD's telehealth platform. Alliance aims to offer comprehensive weight management solutions combining clinical care with lifestyle coaching, targeting a market projected to reach $100 billion by 2030.
• ClearedminorStrategic or Co-development Partner · 12 January 2022Acquisition of allergy telehealth platform Cleared as announced in regulatory filing. Aimed at enhancing LifeMD's telehealth service offerings with allergy and asthma care capabilities.
• NovoCare PharmacycoreTechnology or IntegrationIntegration with Novo Nordisk's NovoCare Pharmacy for GLP-1 medication fulfillment, enabling seamless prescription processing and home delivery of Wegovy and other Novo medications.

Scale indicators15 records

Recent moves11 records

Expansion highlights7 records

Direct peers

• Ro: DTC telehealth company offering weight management (GLP-1s including branded and compounded), men's health, women's health, fertility, and smoking cessation. Closely comparable to LifeMD in business model, product mix, and patient acquisition via digital marketing.
• Hims & Hers Health: Largest direct-to-consumer telehealth competitor offering weight loss (including compounded GLP-1s), men's health, women's health, mental health and primary care on a subscription model. Operates with a similar cash-pay, vertically-integrated online clinic model targeting the same consumer demographic as LifeMD.
• Sesame: DTC telehealth and in-person marketplace offering weight loss (GLP-1s), primary care, mental health and specialty care on a cash-pay basis. Comparable direct-to-consumer model and product portfolio, particularly for GLP-1 weight management.
• WeightWatchers (WW): Subscription-based weight management platform that has expanded into telehealth and GLP-1 prescribing through its Sequence and Clinic programs. Direct overlap with LifeMD's Weight Management Program in target customer and category.

Broad incumbents

• Amwell: Enterprise telehealth infrastructure and virtual care platform serving health systems, insurers and employers. Overlaps with LifeMD in primary and behavioral virtual care but operates more as a B2B technology layer than a consumer brand.
• Teladoc Health: Large incumbent virtual care platform serving employers, health plans and providers with general medical, mental health (BetterHelp) and chronic condition management. Broader and more B2B-oriented than LifeMD, but overlapping in DTC and chronic-care telehealth.

Emerging players

• Done Global: Direct-to-consumer telehealth platform focused on ADHD and mental health treatment, including controlled-substance prescribing. Comparable in telehealth delivery model and consumer marketing approach but narrower in clinical scope.
• Cerebral: Subscription-based mental health telehealth platform providing therapy, counseling and medication management. Overlaps with LifeMD's Mental Health Program in care delivery and subscription pricing model.
• Maven Clinic: Virtual care platform for women's and family health, including fertility, pregnancy, postpartum and menopause care. Comparable to LifeMD's Women's Health Program in target demographic and virtual care delivery.
• Noom: Digital health platform combining behavior change coaching with telehealth and access to GLP-1 medications. Comparable to LifeMD in weight management focus and consumer subscription model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/lifemd
• LinkedInlinkedin.com/company/lifemd-inc
• Instagraminstagram.com/lifemd
• TikToktiktok.com/@lifemd

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries3 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LifeMD